Tao Peng
- Cancer Research top 2%
- MicroRNA in disease regulation 18
- Cancer-related molecular mechanisms research 11
- Molecular Biology top 5%
- Circular RNAs in diseases 11
- Extracellular vesicles in disease 9
- PI3K/AKT/mTOR signaling in cancer 5
- Biophysics top 5%
- Aging top 10%
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 8
-
- Pancreatitis Pathology and Treatment 8
-
- Cancer Mechanisms and Therapy 6
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Tao Peng
98 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 143
- Cancer Research 833
- Molecular Biology 1.8k
- Biophysics 102
- Aging 27
- Oncology 368
Countries citing papers authored by Tao Peng
This map shows the geographic impact of Tao Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Peng more than expected).
Fields of papers citing papers by Tao Peng
This network shows the impact of papers produced by Tao Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Peng. The network helps show where Tao Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tao Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 9 | |
| 6 | 2022 | 9 | |
| 7 | 2021 | 27 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 31 | |
| 12 | 2020 | 20 | |
| 13 | 2020 | 5 | |
| 14 | 2019 | 149 | |
| 15 | 2018 | 284 | |
| 16 | Assessment of Red Blood Cell Distribution Width as an Early Predictor of Persistent Organ Failure in Patients with Acute Pancreatitis | 2017 | 4 |
| 17 | 2015 | 48 | |
| 18 | 2012 | 44 | |
| 19 | Cross-layer design-based power control algorithms for Ad hoc networks | 2009 | 0 |
| 20 | [Construction of pMSCV recombinant retroviral vector containing polo-like kinase 3(plk3) cDNA and its effects on cell proliferation]. | 2006 | 1 |
About Tao Peng
Tao Peng is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 104 papers that have together received 2.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (11 papers), Circular RNAs in diseases (11 papers), Extracellular vesicles in disease (9 papers), Pancreatic and Hepatic Oncology Research (8 papers), Pancreatitis Pathology and Treatment (8 papers), Cancer Mechanisms and Therapy (6 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). The work is most often cited by research in Cancer Research (833 citations), Molecular Biology (1.8k citations) and Biophysics (102 citations). Tao Peng has collaborated with scholars based in China, United States and Germany. Frequent co-authors include David M. Sabatini, Todd R. Golub, Heshui Wu, Jiongxin Xiong, Kai Tan, Ning Zhao, Jing Cui, Xin Zhao, Peng Jiang and Zhonghu Li. Their work appears in journals such as Science, Nature Communications and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.